MIT and EPFL researchers have developed a highly targeted and non-toxic method for battling cancer through immunotherapy. Their nanoparticle gel acts only on immune cells surrounding the tumor, without affecting the rest of the body. The research project began at MIT and was completed at EPFL, in the Laboratory of Biomaterials for Immunoengineering (LBI), headed by Li Tang in the School of Engineering (STI).
Media properties
- Themes
- Research and Tech Transfer , Cancer, STI, Biology
- Copyright
- EPFL - Alain Herzog
- Licence
- CC0 Licence
- Shooting date
- July 9, 2018
- Album
- Smart Nanoparticles keep immunotherapy focused on cancer
Share on
